MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia.

about

Dysregulation of miR-200s clusters as potential prognostic biomarkers in acute myeloid leukemia.

P2860

Q55279230-DDFE9D64-1A95-4D9A-B2BE-EBCA62FD0C77

P2860

MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia.

Item

http://www.wikidata.org/entity/Q52655669

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

MiR-362-5p as a novel prognost ...... normal acute myeloid leukemia.

@en

MiR-362-5p as a novel prognost ...... normal acute myeloid leukemia.

@nl

type

Item

label

MiR-362-5p as a novel prognost ...... normal acute myeloid leukemia.

@en

MiR-362-5p as a novel prognost ...... normal acute myeloid leukemia.

@nl

prefLabel

MiR-362-5p as a novel prognost ...... normal acute myeloid leukemia.

@en

MiR-362-5p as a novel prognost ...... normal acute myeloid leukemia.

@nl

P1476

MiR-362-5p as a novel prognost ...... normal acute myeloid leukemia.

@en

P2093

Huan-Ping Wang

http://www.w3.org/2001/XMLSchema#string

Jing-Han Wang

http://www.w3.org/2001/XMLSchema#string

Min Yang

http://www.w3.org/2001/XMLSchema#string

Qiu-Ling Ma

http://www.w3.org/2001/XMLSchema#string

P2860

Mutations and treatment outcome in cytogenetically normal acute myeloid leukemia.

Favorable prognostic impact of NPM1 mutations in older patients with cytogenetically normal de novo acute myeloid leukemia and associated gene- and microRNA-expression signatures: a Cancer and Leukemia Group B study.

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Evaluation of candidate control genes for diagnosis and residual disease detection in leukemic patients using 'real-time' quantitative reverse-transcriptase polymerase chain reaction (RQ-PCR) - a Europe against cancer program.

Nomenclature evolution: Changes in the ISCN from the 2005 to the 2009 edition.

Long-term follow-up of cytogenetically normal CEBPA-mutated AML

BAALC and ERG expression levels are associated with outcome and distinct gene and microRNA expression profiles in older patients with de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study.

Next generation sequencing profiling identifies miR-574-3p and miR-660-5p as potential novel prognostic markers for breast cancer.

MiR-362-5p promotes the malignancy of chronic myelocytic leukaemia via down-regulation of GADD45α.

miR-126 Regulates Distinct Self-Renewal Outcomes in Normal and Malignant Hematopoietic Stem Cells.

P2888

s12967-018-1445-3

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12967-018-1445-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jie Jin

P577

2018-03-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101531680

http://www.w3.org/2001/XMLSchema#string

P698

29540187

http://www.w3.org/2001/XMLSchema#string

P932

5853092

http://www.w3.org/2001/XMLSchema#string

MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia.

about

P2860

P2860

MiR-362-5p as a novel prognostic predictor of cytogenetically normal acute myeloid leukemia.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P932